Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Mammary Gland Biology and Neoplasia|August 7, 2012
Targeting the PI3K/Akt/mTOR pathway for breast cancer therapyJustin Cidado, Ben Ho Park
Breast Cancer Research : BCR|February 22, 2013
Needles in a haystack: finding recurrent genomic changes in breast cancerJustin Cidado, Julia A Beaver, Ben Ho Park
Transplantation|December 23, 2003
Analysis of cytokine functions in graft rejection by gene expression profilesYurong Liang, Kenneth Christopher, Rachel DeFina, et al.
Elife|July 12, 2019
The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cellsShaheen Kabir, Justin Cidado, Courtney Andersen, et al.
Haematologica|December 23, 2020
Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibitionBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
The AAPS Journal|June 28, 2023
A PKPD Case Study: Achieving Clinically Relevant Exposures of AZD5991 in Oncology Mouse ModelsMichael J White, Letitia Cheatham, Shenghua Wen, et al.
Molecular Cancer Therapeutics|June 28, 2019
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell LymphomaTaylor Hashiguchi, Nur Bruss, Scott Best, et al.
Blood|December 1, 2020
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomasScott Boiko, Theresa Proia, Maryann San Martin, et al.
Blood Advances|November 19, 2024
Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical modelsSankaranarayanan Kannan, Yizhen Li, Natalia Baran, et al.
Human Pathology|May 15, 2014
Analysis of BRCA2 loss of heterozygosity in tumor tissue using droplet digital polymerase chain reactionRory L Cochran, Karen Cravero, David Chu, et al.
Pageof 4